JAN POOLMAN, PH.D.
HEAD, BACTERIAL VACCINES DISCOVERY AND EARLY DEVELOPMENT
DAS LEADER, BACTERIAL VACCINES
In his role, Jan Poolman, Ph.D., oversees the development of new vaccines against prevalent bacteria that are resistant to antibiotics.
Previously, from 1986-1996, Jan was Head of Vaccines R&D at the National Institute for Public Health and the Environment in the Netherlands. In 1997 he was appointed Head & Vice President, Bacterial Vaccines R&D at GSK Biologicals in Belgium. During his tenure until 2011, he contributed to the licensure of several products, including pertussis combinations, meningococcal and pneumococcal vaccines.
Jan obtained a Master of Science in Chemistry in 1975 and a Ph.D. in Meningococcal Surface Structure in 1981 from the University of Amsterdam. In 1982 he was awarded an NIH post-doctoral fellowship research position at the University of Washington in Seattle, USA. In 1983, Jan returned to the University of Amsterdam as Assistant-Professor Bacteriology.
Jan has published more than 200 articles in peer-reviewed journals and is a member of the Editorial Board for the Expert Review of articles for the journal Vaccines.